Amjevita - NDC Database

13 records found

Page:1

50090-6411 Jan 31, 2023
Amjevita 40 mg/.8ml Subcutaneous Injection by A-s Medication Solutions

50090-6428 Jan 31, 2023
Amjevita 40 mg/.8ml Subcutaneous Injection by A-s Medication Solutions

55513-399 Aug 14, 2023
Amjevita 20 mg/.2ml Subcutaneous Injection by Amgen Inc

55513-400 Jan 31, 2023
Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen Inc

55513-410 Jan 31, 2023
Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen Inc

55513-411 Jan 31, 2023
Amjevita 20 mg/.4ml Subcutaneous Injection by Amgen Inc

55513-413 Apr 06, 2023
Amjevita 10 mg/.2ml Subcutaneous Injection by Amgen Inc

55513-479 Aug 14, 2023
Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen Inc

55513-480 Aug 14, 2023
Amjevita 80 mg/.8ml Subcutaneous Injection by Amgen Inc

55513-481 Aug 14, 2023
Amjevita 80 mg/.8ml Subcutaneous Injection by Amgen Inc

55513-482 Aug 14, 2023
Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen Inc

72511-400 Jan 31, 2023
Amjevita 40 mg/.8ml Subcutaneous Injection by Amgen USA Inc.

72511-482 Aug 14, 2023
Amjevita 40 mg/.4ml Subcutaneous Injection by Amgen USA Inc.

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.